|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 11, 2016 ) According to Center for Disease Control and Prevention in 2011, in the U.S., one in 691 live births is diagnosed with Down syndrome. Increasing healthcare expenditure, improving testing technology to increase accuracy and reduce duration of result generation, and shifting inclination towards child bearing at later maternal age are expected to support the growth of the market in the forecasted period.
Explore more or request TOC on Global Non-Invasive Prenatal Testing (NIPT) Market at: https://www.psmarketresearch.com/market-analysis/non-invasive-prenatal-testing-market
Massive unexplored market in non-invasive prenatal testing industry of developing economies is creating ample opportunities for the non-invasive prenatal testing market to grow at a considerable rate during the forecasted period. The advanced research and development facilities, and innovative test developments by the companies are propelling the growth of the non-invasive prenatal testing industry. Non-invasive prenatal testing is preferred by gynecologists and expected mothers as it is accurate, non-invasive and safe compared to invasive tests, such as chorionic villus sampling, nuchal translucency and aminocentesis. Non-invasive methods can detect chromosomal abnormalities in fetuses as early as nine to ten weeks of gestation.
Some of the factors driving the growth of non-invasive prenatal testing market are increasing incidence rate of babies born with Down syndrome, increasing average maternal rate, technological advancement to detect signal gene disorders, no risk of miscarriage with non-invasive prenatal testing, and increasing demand for early and non-invasive fetal testing procedure. In addition, increasing healthcare expenditure and increasing awareness of non-invasive prenatal testing are also expected to fuel the growth of the market in the forecasted period.
Geographically, North America will be leading the global non-invasive prenatal testing market in the coming years due to penetrating awareness level for non-invasive prenatal testing and high healthcare expenditure. Asia-Pacific is the fastest growing region in the global non-invasive prenatal testing market. The major reasons for the fastest growth of non-invasive prenatal testing market in the region are mounting healthcare expenditure, large women population preferring late pregnancy, and increasing acceptance of these tests in the region. Moreover, the non-invasive prenatal testing market is growing due to increasing awareness of prenatal testing in the emerging countries, such as India and China.
Browse related market research at: https://www.psmarketresearch.com/industry-report/medical-devices
Some of the companies operating in the global non-invasive prenatal testing market are Laboratory Corporation of America Holdings (LapCorp), Ariosa Diagnostics Inc, Sequenom Inc., LifeCodexx AG, BGI Diagnostics, Berry Genomics Co. Ltd., Natera Inc., and Illumina Inc.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
US/ Canada Toll-Free: 1-888-778-7886
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
P&S Market Research
Abhishek
1-888-778-7886
enquiry@psmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
